Study title: 2.3.9 Collins IS, Morton FJ (1968). Mecloprodin (Tavegyl) – a new antihistamine: clinical trials in Australia 1966-1967. 2.3.9 Collins IS, Morton FJ (1968). Mecloprodin (Tavegyl) – a new antihistamine: clinical trials in Australia 1966-1967.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Immune System Diseases [C20] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: CLEMASTINE | |||||
ATC code: | |||||
Document link: 2011_EMAspreadsheet_Tavegil_1mg_Tablets_Collins IS_1968.xls | |||||
Document date: 2011-11-10 | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |